Examining the impact of several factors including COVID-19 on thyroid fine-needle aspiration biopsy

Basit Öğe Kaydı
dc.contributor.authorDeniz, Muzaffer Serdar
dc.contributor.authorDindar, Merve
dc.date.accessioned2024-09-29T15:50:39Z
dc.date.available2024-09-29T15:50:39Z
dc.date.issued2023
dc.departmentKarabük Üniversitesien_US
dc.description.abstractObjective: The study explores various factors, including coronavirus disease 2019 (COVID-19) history and vaccination status, that influence the classification value of ultrasonography-guided thyroid fine needle aspiration biopsy (TFNAB) by comparing non-diagnostic (Bethesda-I) and diagnostic (Bethesda II-VI) results. Methods: We conducted a retrospective observational study in a high-volume tertiary care center involving patients who underwent TFNAB from November 2022 to April 2023. The study retrospectively analyzed the cytopathology of 482 thyroid nodules. Patients were categorized into non-diagnostic (n = 136) and Diagnostic groups (n = 346) based on TFNAB. A comprehensive set of parameters was examined, including demographic, anthropometric and clinical data, thyroid ultrasonography findings, COVID-19 history and immunization status. Results: The mean age was 55.1 +/- 12.1 years in the non-diagnostic group and 53.5 +/- 13 years in the Diagnostic group (p = .223). 75.7% (n = 103) of the non-Diagnostic group and 82.9% (n = 287) of the Diagnostic group were male (p = .070). The mean nodule longitudinal diameter of the Diagnostic group was significantly higher than that of the non-diagnostic group (p = .015). The TIRADS score of the nodules showed a statistical difference between the groups (p = .048). The groups had no significant differences regarding other ultrasonographic parameters and COVID-19-related variables. Conclusion: It can be assumed that when the longitudinal diameter of the thyroid nodule is small and in TIRADS categories other than the TIRADS3 category, TFNAB is less likely to be diagnostic. However, future research may be needed to confirm these findings and uncover any long-term effects of COVID-19 or vaccines on thyroid nodule diagnostics.en_US
dc.identifier.doi10.1002/dc.25239
dc.identifier.issn8755-1039
dc.identifier.issn1097-0339
dc.identifier.pmid37823334en_US
dc.identifier.scopus2-s2.0-85173874099en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.urihttps://doi.org/10.1002/dc.25239
dc.identifier.urihttps://hdl.handle.net/20.500.14619/3661
dc.identifier.wosWOS:001083957800001en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofDiagnostic Cytopathologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBethesdaen_US
dc.subjectCOVID-19en_US
dc.subjectnodule diameteren_US
dc.subjectthyroid fine needle aspiration biopsyen_US
dc.subjectthyroid ultrasonographyen_US
dc.titleExamining the impact of several factors including COVID-19 on thyroid fine-needle aspiration biopsyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu